Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today declared that it had agreed to sell its hospital goods to Dr. Reddy’s Laboratories SA, a division of Dr. Reddy’s Laboratories, Ltd. (collectively, “Dr. Reddy’s”) (NYSE: RDY), for a maximum payment of $50 million.
Sean Brynjelsen, CEO of Eton Pharmaceuticals said “The sale of our hospital products allows us to focus our resources on our core rare disease business, which is rapidly growing, and also provides an attractive opportunity to monetize the value we have created with ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap . Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here .
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer .
For further details see:
Eton Pharmaceuticals Sells Hospital Supplies to Dr. Reddy’s for up to $50M